you are here:

Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals

BSE Live

Jul 27, 16:00
1040.35 -16.40 (-1.55%)
Volume
AVERAGE VOLUME
5-Day
13,039
10-Day
17,629
30-Day
31,256
18,572
  • Prev. Close

    1056.75

  • Open Price

    1064.90

  • Bid Price (Qty.)

    1030.00 (1)

  • Offer Price (Qty.)

    1040.35 (10)

NSE Live

Jul 27, 15:57
1038.90 -18.50 (-1.75%)
Volume
AVERAGE VOLUME
5-Day
420,754
10-Day
399,296
30-Day
603,346
726,724
  • Prev. Close

    1057.40

  • Open Price

    1059.00

  • Bid Price (Qty.)

    1038.90 (39)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2020 2019 2018 2017 2016
Cash Flow of Natco Pharma (in Rs. Cr.) Mar 21 Mar 20 Mar 19 Mar 18 Mar 17  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 0.00 583.10 847.40 887.60 634.10  
Net CashFlow From Operating Activities 0.00 422.50 698.80 476.40 329.80  
Net Cash Used In Investing Activities 0.00 -165.00 -645.20 -1,131.10 -290.60  
Net Cash Used From Financing Activities 0.00 -261.10 -52.20 652.00 -45.60  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents 0.00 -3.60 1.40 -2.70 -6.40  
Cash And Cash Equivalents Begin of Year 0.00 11.50 10.10 12.80 19.20  
Cash And Cash Equivalents End Of Year 0.00 7.90 11.50 10.10 12.80  
Source : Dion Global Solutions Limited